Literature DB >> 8856694

Pleasure-attenuation of startle is disrupted by lesions of the nucleus accumbens.

M Koch1, A Schmid, H U Schnitzler.   

Abstract

The nucleus accumbens (NAC) and the amygdala have been implicated in processes by which reinforcers control instrumental behaviour. Reinforcement has both motivational and motor components, and it is necessary to differentiate between these two aspects. The acoustic startle response (ASR) is attenuated in the presence of a secondary reinforcer. In contrast to other paradigms used for investigating mechanisms of reward, the "pleasure-attenuated startle" (PAS) paradigm indicates the rewarding properties of a treatment by an attenuation rather than by reinforcement of a response, thus allowing determination of the motivational impact of a treatment independent from its motor stimulating effects. Here, we report that the ASR was attenuated in the presence of a positive conditioned stimulus in shamoperated animals and in rats with lesions of the amygdala, but not in animals bearing 6-hydroxydopamine lesions of the NAC. These findings suggest that the catecholaminergic innervation of the NAC is important for behavioural control by conditioned reward.

Entities:  

Mesh:

Year:  1996        PMID: 8856694     DOI: 10.1097/00001756-199605310-00024

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  26 in total

Review 1.  [Cue-induced alcohol craving. Neurobiological correlates and clinical relevance].

Authors:  J Wrase; S M Grüsser; A Heinz
Journal:  Nervenarzt       Date:  2006-09       Impact factor: 1.214

2.  Activity of the positive and negative reinforcement motivation systems and baseline arterial blood pressure in humans.

Authors:  L I Aftanas; P V Sidorova; S V Pavlov; V P Makhnev; V V Korenek; N V Reva; T G Amstislavskaya
Journal:  Neurosci Behav Physiol       Date:  2008-09-18

Review 3.  Linking dimensional models of internalizing psychopathology to neurobiological systems: affect-modulated startle as an indicator of fear and distress disorders and affiliated traits.

Authors:  Uma Vaidyanathan; Christopher J Patrick; Bruce N Cuthbert
Journal:  Psychol Bull       Date:  2009-11       Impact factor: 17.737

Review 4.  Influence of emotional states on inhibitory gating: animals models to clinical neurophysiology.

Authors:  Howard C Cromwell; Rachel M Atchley
Journal:  Behav Brain Res       Date:  2014-05-23       Impact factor: 3.332

5.  Amphetamine injections into the nucleus accumbens affect neither acquisition/expression of conditioned fear nor baseline startle response.

Authors:  Isabel Schwienbacher; Markus Fendt; Hans-Ulrich Schnitzler
Journal:  Exp Brain Res       Date:  2004-12-10       Impact factor: 1.972

6.  Heritability and molecular genetic basis of acoustic startle eye blink and affectively modulated startle response: a genome-wide association study.

Authors:  Uma Vaidyanathan; Stephen M Malone; Michael B Miller; Matt McGue; William G Iacono
Journal:  Psychophysiology       Date:  2014-12       Impact factor: 4.016

7.  Emotion potentiated startle in fragile X syndrome.

Authors:  Elizabeth C Ballinger; Lisa Cordeiro; Alyssa D Chavez; Randi J Hagerman; David Hessl
Journal:  J Autism Dev Disord       Date:  2014-10

8.  Alcohol expectancies and reactivity to alcohol-related and affective cues.

Authors:  David J Drobes; Ashlee C Carter; Mark S Goldman
Journal:  Exp Clin Psychopharmacol       Date:  2009-02       Impact factor: 3.157

9.  A rift between implicit and explicit conditioned valence in human pain relief learning.

Authors:  Marta Andreatta; Andreas Mühlberger; Ayse Yarali; Bertram Gerber; Paul Pauli
Journal:  Proc Biol Sci       Date:  2010-03-31       Impact factor: 5.349

10.  Opioid-receptor antagonism increases pain and decreases pleasure in obese and non-obese individuals.

Authors:  Rebecca C Price; Nicolas V Christou; Steven B Backman; Laura Stone; Petra Schweinhardt
Journal:  Psychopharmacology (Berl)       Date:  2016-09-22       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.